Literature DB >> 9990556

Neuropsychiatric manifestations of multiple sclerosis.

C Diaz-Olavarrieta1, J L Cummings, J Velazquez, C Garcia de la Cadena.   

Abstract

The range of neuropsychiatric symptoms in multiple sclerosis (MS) has not been prospectively assessed. The authors, working at a tertiary medical center in Mexico City, used the Neuropsychiatric Inventory (NPI) to evaluate neuropsychiatric symptoms prospectively in 44 MS patients who were stable between relapses and 25 control subjects of similar age, education, and cognitive function. Neuropsychiatric symptoms were present in 95% of patients and 16% of control subjects. Changes present were depressive symptoms (79%), agitation (40%), anxiety (37%), irritability (35%), apathy (20%), euphoria (13%), disinhibition (13%), hallucinations (10%), aberrant motor behavior (9%), and delusions (7%). The only relationships with MRI were between euphoria and hallucinations and moderately severe MRI abnormalities. The authors conclude that diverse types of neuropsychiatric symptoms are common in MS; symptoms are present between exacerbations; and there are variable correlations with MRI abnormalities.

Entities:  

Mesh:

Year:  1999        PMID: 9990556     DOI: 10.1176/jnp.11.1.51

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  24 in total

Review 1.  Apathy in neurologic disorders.

Authors:  J Duffy
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

Review 2.  Are the available apathy measures reliable and valid? A review of the psychometric evidence.

Authors:  Diana E Clarke; Jean Y Ko; Emily A Kuhl; Robert van Reekum; Rocio Salvador; Robert S Marin
Journal:  J Psychosom Res       Date:  2010-03-31       Impact factor: 3.006

3.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

4.  Neuropsychiatric manifestations of multiple sclerosis.

Authors:  Laura C Politte; Jeff C Huffman; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

5.  Improvement of neuropsychiatric symptoms in multiple sclerosis subsequent to high-dose corticosteroid treatment.

Authors:  Jan Thöne; Elke Kessler
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 6.  Organic psychosis: Insight into the biology of psychosis.

Authors:  N T Lautenschlager; H Förstl
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

7.  Relapsing-remitting type multiple sclerosis with olfactory hallucinosis and secondary delusions.

Authors:  Jae H Choi; Ulrich W Preuss
Journal:  BMJ Case Rep       Date:  2009-05-25

Review 8.  Psychiatric presentations/manifestations of medical illnesses.

Authors:  Jack Castro; Stephen Billick
Journal:  Psychiatr Q       Date:  2013-09

Review 9.  Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.

Authors:  Stacey Murray; Andrew Woo
Journal:  Ther Adv Neurol Disord       Date:  2015-12-07       Impact factor: 6.570

Review 10.  Psychotic symptoms in patients with medical disorders.

Authors:  Ashwin A Patkar; Rajnish Mago; Prakash S Masand
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.